Volume 52, Issue 6, Pages (December 2007)

Slides:

Advertisements

Similar presentations

Pascal Rischmann European Urology Supplements

Advertisements

Volume 49, Issue 1, Pages (January 2006)

Volume 53, Issue 3, Pages (March 2008)

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

A System for Long-term Urodynamic Studies Without Catheters

Volume 70, Issue 6, Pages (December 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Volume 50, Issue 1, Pages (July 2006)

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 61, Issue 5, Pages (May 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 71, Issue 4, Pages (April 2017)

Volume 49, Issue 1, Pages (January 2006)

Volume 53, Issue 5, Pages (May 2008)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 45, Issue 4, Pages (April 2004)

Volume 57, Issue 5, Pages (May 2010)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 46, Issue 6, Pages (December 2004)

Volume 62, Issue 3, Pages (September 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Volume 51, Issue 2, Pages (February 2007)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 63, Issue 5, Pages (May 2013)

Volume 64, Issue 4, Pages (October 2013)

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Volume 60, Issue 1, Pages (July 2011)

Volume 64, Issue 3, Pages (September 2013)

Volume 72, Issue 3, Pages (September 2017)

Counselling the Prostate Cancer Patient

Volume 51, Issue 5, Pages (May 2007)

Volume 49, Issue 6, Pages (June 2006)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 69, Issue 2, Pages (February 2016)

Functional Bladder Problems

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 57, Issue 5, Pages (May 2010)

Trends in Hypospadias Surgery: Results of a Worldwide Survey

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 70, Issue 6, Pages (December 2016)

Volume 54, Issue 2, Pages (August 2008)

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 50, Issue 5, Pages (November 2006)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Volume 52, Issue 6, Pages (December 2007)

Testicular Cancer Variations in Time and Space in Europe

Meta-Analysis of Botulinum Toxin A Detrusor Injections in the Treatment of Neurogenic Detrusor Overactivity After Spinal Cord Injury Swati Mehta, MA,

Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report1 Dennis D Dykstra, MD,

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

Volume 55, Issue 3, Pages (March 2009)

Botulinum Toxin Type A Injections for Treating Neurogenic Detrusor Overactivity Combined With Low-Compliance Bladder in Patients With Spinal Cord Lesions

Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies David A. Ginsberg, MD, Lynne Kolton.

Economic Burden of Bladder Cancer Across the European Union

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 75, Issue 6, Pages (June 2019)

Medical Treatment of Overactive Bladder: In Response

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 52, Issue 6, Pages 1729-1735 (December 2007) Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity André Reitz, Pierre Denys, Christophe Fermanian, Brigitte Schurch, Eva Comperat, Emmanuel Chartier-Kastler European Urology Volume 52, Issue 6, Pages 1729-1735 (December 2007) DOI: 10.1016/j.eururo.2007.08.052 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 (A) Interinjection intervals (in days; median and interquartile interval). (B) Intervals between injection and urodynamic studies (in days; median and interquartile interval). (C) Continence percent with 95% confidence interval. European Urology 2007 52, 1729-1735DOI: (10.1016/j.eururo.2007.08.052) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 (D) Reflex volume in all patients (in milliliters; median and interquartile interval). (E) Overactivity percent with 95% confidence interval. (F) Reflex volume in patients with persisting overactivity after injection (in milliliters; median and interquartile interval). European Urology 2007 52, 1729-1735DOI: (10.1016/j.eururo.2007.08.052) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 (G) Maximum cystometric bladder capacity (in milliliters; median and interquartile interval). (H) Maximum detrusor pressure (in cm H2O; median and interquartile interval). (I) Detrusor compliance (in ml/cm H2O; median and interquartile interval). European Urology 2007 52, 1729-1735DOI: (10.1016/j.eururo.2007.08.052) Copyright © 2007 European Association of Urology Terms and Conditions